View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Franklin Financial Services Corp: 1 director

A director at Franklin Financial Services Corp bought 7,350 shares at 33.920USD and the significance rating of the trade was 82/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

Soomit Datta
  • Soomit Datta

PayPal (BUY, TP: $100, +25%) - Solid beat at Q4; branded concerns appe...

PayPal reported another solid quarter, coming in ahead of expectations: 4% at transaction margin $ and 6% at non-GAAP EPS. Guidance for FY 25 suggests a small uplift to TM$ and EPS for the street though the bears seem (still) very focused on branded TPV growth.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Insight Enterprises, Inc. to Report Fourth Quarter and Full Year 2024 ...

CHANDLER, Ariz.--(BUSINESS WIRE)-- Insight Enterprises, Inc. (Nasdaq: NSIT) (the “Company”) today announced that it will release financial results for the quarter ended December 31, 2024, prior to market open on February 6, 2025, and will also host a conference call and live webcast at 9:00 a.m. ET to discuss the results of operations. The live webcast and replays of the conference call can be accessed at: To access the live conference call, please register in advance using this . Upon registering, participants will receive dial-in information via email, as well as a unique registrant ID, e...

 PRESS RELEASE

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule ...

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 35,250 shares of Class A common stock and restricted stock units (RSUs) for 17,625 shares of Class A common stock to six new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’ employment in acc...

 PRESS RELEASE

Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dua...

Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor BRISBANE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced an exclusive license agreement with Stanford University for a novel, next generation fusion protein targeting BAFF and APRIL, known as VT-109, with wide therapeutic potential across the spectrum of B cell mediated diseases. “This n...

Soomit Datta
  • Soomit Datta

In-Payments: a new bi-weekly blog! Paze to be Fastlane? Click to Pay ...

To kick off 2025 we’re launching “In-Payments”, a bi-weekly blog which will leverage off recent news flow for a quick dive into what we see as key themes to be tracking across the Payments and broader Fintech space.

 PRESS RELEASE

Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Health...

Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference BRISBANE, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company’s management team will present at the 43rd Annual J.P. Morgan Healthcare Conference, which is taking place in San Francisco, CA from January 12 – 16, 2025. The management team will also participate in one-on-one investor m...

Fidelity National Information Services, Inc.: Key facts and statistics...

A summary company profile, detailing Fidelity National Information Services, Inc.’s business operations and financial highlights.

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Fidelity National Information Services, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 12 December 2024 in which we reassessed the appropriateness of...

Ringcentral Inc: 1 director

A director at Ringcentral Inc sold 17,212 shares at 42.057USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule ...

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on December 3, 2024, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 171,750 shares of Class A common stock and restricted stock units (RSUs) for 86,625 shares of Class A common stock to seventeen new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’ employmen...

 PRESS RELEASE

Insight Signs Strategic Collaboration Agreement with AWS to Accelerate...

CHANDLER, Ariz.--(BUSINESS WIRE)-- (NASDAQ:NSIT) announced today that it has signed a new Strategic Collaboration Agreement (SCA) with Amazon Web Services, Inc. (AWS) to more effectively help clients manage their cloud roadmap, including . The SCA strengthens Insight’s role as a leading provider of cloud, data, artificial intelligence, cybersecurity, and intelligent edge solutions across multiple cloud ecosystems. As organizations leverage the cloud to modernize architecture, boost compute, and strengthen security, Insight optimizes clients’ AWS usage with a streamlined experience for manag...

 PRESS RELEASE

Insight Announces Date and Webcast Information for Upcoming Investor E...

CHANDLER, Ariz.--(BUSINESS WIRE)-- Insight Enterprises, Inc. (Nasdaq: NSIT) (the “Company”) today announced that it is scheduled to participate in the following upcoming investor conferences: Wells Fargo 8th Annual TMT Summit December 3, 2024, 8:00 AM PT Participants: Joyce Mullen, CEO and James Morgado, SVP Finance and CFO, North America Raymond James 2024 TMT & Consumer Conference December 9, 2024, 10:40 AM ET Participants: James Morgado, SVP Finance and CFO, North America The Insight presentation will be broadcast live over the Internet at where you can also view other recent webcast...

Soomit Datta
  • Soomit Datta

PYPL US (BUY, TP: $100, +12%) SQ US (Neutral, TP $70 - UR) CFPB overs...

The Consumer Financial Protection Bureau (CFPB) issued a finalized version of a rule at the end of last week, saying it will soon supervise non-bank firms, including PayPal and Block, that offer financial services. With an inbound Trump, does this still matter?

 PRESS RELEASE

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule ...

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on November 18, 2024, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of a non-qualified stock option to purchase 108,000 shares of Class A common stock and restricted stock units (RSUs) for 53,000 shares of Class A common stock to Jason S. Carter, Vera’s new Chief Legal Officer, under Vera’s 2024 Inducement Plan. The Compensation Committee approved the a...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Fidelity National Information Services Inc: 1 director

A director at Fidelity National Information Services Inc sold 11,305 shares at 87.970USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch